Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | -10.80% |
|
+32.67% | -.--% |
05-28 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
05-28 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
138M | - | - | - | - | - | |
121B | ||||||
113B | ||||||
26.02B | - | |||||
19.39B | - | |||||
15.91B |